Collective News

Introducing Collective Go

Helping to reduce risk with an evidence-based solution for a safer return to work

With the U.S. economy facing its sharpest decline since the Great Depression, and national unemployment now at ~14% and climbing, we know that we must carve a path back to a new normal in the months and years ahead.

As cities loosen restrictions on sheltering-in-place, we have to accept that this is not a zero risk proposition. While there’s reason for optimism in our fight against COVID-19, leaving our homes inevitably presents risk.

This is especially true in our jobs and when re-entering our workplaces. While remote work has proven to be a viable option for some companies, the reality is most of us will have to physically go back to work at some point. For many people, it is essential.

As businesses think about how to bring people back safely, we believe there are four key questions they should be asking:

There is no one-size fits all return to work strategy

Businesses are caught between a failure of public health in widespread testing, and the political and economic pressure to re-open, leaving them to make decisions many are simply not equipped to make—decisions that might not be supported by the latest science and public health research.

When and how people return to work has to vary based on industry and type of work, geography, and local epidemiology data. We believe that these factors, combined with an evidence-based approach for frequent, verifiable, large-scale testing and monitoring present the only viable way to return Americans safely to work.

Businesses need new evidence-based capabilities to implement work and workplace modifications, appropriate testing, and most of all support for their employees in improving safety today and for the future. I appreciate Collective Health’s commitment to meeting that critical need.

– Mark McClellan, Director of the Duke-Margolis Center for Health Policy and Former CMS Administrator and FDA Commissioner

Introducing Collective Go™

We’re excited to introduce Collective Go™, a product designed to help businesses and their workers reduce risk and navigate safer workforce reentry, with a measured and evidence-based approach.

What makes Collective Go™ different?

Comprehensive protocol to perform risk assessment, screening, and testing of workers

Collective Go™ features a peer-reviewed occupational health protocol1 underpinning its testing process, tailored to address risks associated with specific job types and worker populations. The protocol will serve as a continuously-updated guideline to help businesses understand and help to minimize risk of coronavirus introduction in the workplace. The protocol can currently be read in its entirety on OSF, an open source resource for scientific protocols.

Read the protocol.

As part of the protocol, Collective Health developed a series of models with extensive third party review, which:

  • Describe how standard measures—temperature checks, disinfection, physical distancing, and masks—can help to reduce risk.
  • Provide guidance about testing types, frequency, and for what populations, which will differ based on industry, environment, geography, and workforce makeup, roles, and responsibilities.


1. The protocol underpinning Collective Go was developed by Collective Health’s Sanjay Basu MD PhD, and co-authored by Rajaie Batniji MD DPhil, with peer review from modeling experts and infectious disease epidemiologists, including: Kirsten Bibbins-Domingo MD PhD, University of California San Francisco, Elizabeth Chin MS, Stanford University, Ben Huynh MS, Stanford University, Nathan Lo MD PhD, University of California San Francisco, Mark McClellan MD PhD, Duke University, Matthew Murrill MD PhD, Johns Hopkins Bloomberg School of Public Health, George Rutherford MD, University of California San Francisco, and Lisa Winston MD, University of California San Francisco. The underlying models utilized in the model have been submitted to academic journals and are currently undergoing peer review.
Ecosystem of clinical and testing partners

With a network of testing partners and the ability to receive data input from any lab, Collective Go™ offers businesses scalability and flexibility to adapt to the rapidly-evolving testing landscape, and adopt the testing type most appropriate for their workforce.

Enterprise and consumer-grade technology applications

For workers, Collective Go™ will introduce a simple and privacy-oriented app experience with symptom and exposure checking, test status monitoring, and certification of compliance with business workplace testing protocols.

For businesses, Collective Go™ will provide access to a HIPAA-compliant platform capable of securely receiving data from a variety of testing labs, with management tools to deliver insights on how the workforce is tracking towards successful risk reduction and reentry.

So what does this look like?
Availability

Collective Go™ is first focused on supporting businesses with U.S. workers in essential roles as defined by local government authorities, and will expand over time to include support for any U.S. worker, regardless of geography, industry, or job type. Collective Go™ will begin rolling out in June 2020.

For more details in the meantime, please view our press release.

Interested in learning more?

Our customers include:
Red Bull Activision Blizzard
Zendesk Counsyl
Red Bull Trace3 DataSafe
Red Bull
Activision Blizzard
Zendesk Counsyl
Trace3 DataSafe
Red Bull Activision Blizzard Zendesk Counsyl Trace3 DataSafe